Currently it is established that Her-2 (human epidermal growth factor receptor-2), Estrogen Receptor (ER), and Progesterone Receptor (PR) are the most commonly used biomarkers and therapeutic targets in breast cancer patients. Here, ESR1 is linked to breast carcinoma.